ATAGI 2026 influenza update: what’s changed?

Industry

2 March 2026

The Australian Technical Advisory Group on Immunisation (ATAGI) released its Statement on the administration of seasonal influenza vaccines in 2026 late last week, in the wake of Australia’s deadliest influenza season this century.

In 2025, around 1,701 influenza-associated deaths were recorded, more than those related to COVID-19 – which fell compared to the previous year.

Against that backdrop, improving vaccine uptake, particularly in priority populations, is a clear national focus.

Here are the top takeaways for pharmacists this influenza season.

1. Intranasal influenza vaccine introduced

This year, the live attenuated influenza vaccine (LAIV), FluMist, administered intranasally, is available for the first time.

FluMist is registered for children and adolescents aged 2–17 years and is available as a private vaccine and through selected state programs in:

New South Wales
Queensland
South Australia
Western Australia.

While ATAGI considers LAIV to have comparable effectiveness to inactivated influenza vaccines, there are important eligibility considerations:

LAIV is contraindicated in people with moderate or severe immunocompromise
it should not be administered in pregnancy
inactivated influenza vaccines remain the recommended option for adults and at-risk populations.

As with other influenza vaccines, LAIV can be administered at the same time as, or at any interval before or after, other vaccines. The availability of a needle-free option may also influence vaccine uptake in needle-averse children and adolescents.

2. The end of quadrivalent vaccines

All influenza vaccines available in 2026 are trivalent. The B/Yamagata lineage has been removed from vaccine formulations, reflecting global surveillance data suggesting it may no longer be circulating.

In 2026, influenza vaccines will contain two A strains and one B strain. This aligns Australia with the World Health Organization’s recommendation to move to trivalent formulations.

3. Expanded registration of Fluad

The adjuvanted influenza vaccine Fluad is now registered for adults aged 50 years and over. Previously, adjuvanted influenza vaccines were only registered for adults aged 65 years and over.

However, National Immunisation Program (NIP) funding arrangements remain unchanged, with Fluad only NIP-funded for people aged 65 years and over.

4. Timing and urgency after a severe season

The Chief Medical Officer, Professor Michael Kidd AO reinforced that annual influenza vaccination remains the most important measure to prevent complications from influenza.

Vaccination is recommended from mid-April to ensure protection ahead of winter.

Patients who received a 2025 influenza vaccine in late 2025 or early 2026 are still recommended to receive the 2026 formulation.

NIP stock will be available for ordering from April 2026, depending on supply arrangements in each state and territory.

5. Vaccination rates remain dangerously low

Although small improvements in influenza vaccination rates were seen in 2025, coverage remains significantly below pre-2023 levels – particularly among vulnerable groups.

While uptake in children under 5 slightly increased from 25.8% in 2024 to 26.1% in 2025, it remains well below the 2022 rate of 31.9%. Rates among Aboriginal and Torres Strait Islander people reduced from 22.7% in 2024 to 22.4% in 2025.

Prof Kidd emphasised the importance of increasing uptake among these groups.

‘Your recommendation to your patients is one of the most influential drivers of vaccination acceptance,’ he said. ‘Research shows that a strong, confident endorsement from a trusted health professional makes a significant impact on patient decision-making.’

More information for pharmacists

To support pharmacists preparing for the 2026 season, PSA will host an online member-only briefing on Tuesday 3 March 2026.

The session will provide further detail on ATAGI’s 2026 advice, including vaccine formulation changes and the role of intranasal influenza vaccine.

With last year’s influenza season the most severe this century, preparedness, clear communication and confident recommendation will be central to protecting communities in 2026.

Register to attend PSA’s member-only briefing: 2026 ATAGI influenza statement.

8.00 am	Set up and check in IVF work fluctuates – some days it’s minimal, other days it’s constant. I check what’s booked/expected, confirm any urgent needs, and make sure there’s space for IVF stock.
9.00 am	Ordering and supply planning Weekly ordering is done on Monday mornings and reviewed again on Wednesday because we can’t reliably order later in the week. This helps to protect continuity.
10:30 am	Dispensary coordination My dispensary manager leads ordering of IVF medicines, support materials and consumables. She also prepares syringe/needle packs for medicines that require separate consumable supply, so patients receive everything together.
12.00 pm	Clinic liaison Phone or email contact with IVF nurses occurs most days to clarify prescriptions, confirm timing and align supply with treatment cycles.
2.00 pm	Prescription collection Our courier collects prescriptions from fertility clinics weekly, as not all clinics use e-scripts. These are processed promptly to avoid delays that could affect treatment timing.
3.30 pm	Patient support IVF supply often includes practical support: ensuring patients have what they need for transport and storage, and that any supporting materials and consumables are ready alongside the medicines.
6.00 pm	Engagement and training Some evenings may include a Fertility Nurses of Australia meeting, or delivering training sessions for fertility clinics for IVF clinicians and nurses.
8.00 pm	Urgent supply Occasionally I’ll get an out-of-hours call from an IVF clinician to arrange emergency medicines supply, requiring rapid coordination to keep treatment on track.

8.00 am	Set up and check in IVF work fluctuates – some days it’s minimal, other days it’s constant. I check what’s booked/expected, confirm any urgent needs, and make sure there’s space for IVF stock.
9.00 am	Ordering and supply planning Weekly ordering is done on Monday mornings and reviewed again on Wednesday because we can’t reliably order later in the week. This helps to protect continuity.
10:30 am	Dispensary coordination My dispensary manager leads ordering of IVF medicines, support materials and consumables. She also prepares syringe/needle packs for medicines that require separate consumable supply, so patients receive everything together.
12.00 pm	Clinic liaison Phone or email contact with IVF nurses occurs most days to clarify prescriptions, confirm timing and align supply with treatment cycles.
2.00 pm	Prescription collection Our courier collects prescriptions from fertility clinics weekly, as not all clinics use e-scripts. These are processed promptly to avoid delays that could affect treatment timing.
3.30 pm	Patient support IVF supply often includes practical support: ensuring patients have what they need for transport and storage, and that any supporting materials and consumables are ready alongside the medicines.
6.00 pm	Engagement and training Some evenings may include a Fertility Nurses of Australia meeting, or delivering training sessions for fertility clinics for IVF clinicians and nurses.
8.00 pm	Urgent supply Occasionally I’ll get an out-of-hours call from an IVF clinician to arrange emergency medicines supply, requiring rapid coordination to keep treatment on track.

8.00 am	Set up and check in IVF work fluctuates – some days it’s minimal, other days it’s constant. I check what’s booked/expected, confirm any urgent needs, and make sure there’s space for IVF stock.
9.00 am	Ordering and supply planning Weekly ordering is done on Monday mornings and reviewed again on Wednesday because we can’t reliably order later in the week. This helps to protect continuity.
10:30 am	Dispensary coordination My dispensary manager leads ordering of IVF medicines, support materials and consumables. She also prepares syringe/needle packs for medicines that require separate consumable supply, so patients receive everything together.
12.00 pm	Clinic liaison Phone or email contact with IVF nurses occurs most days to clarify prescriptions, confirm timing and align supply with treatment cycles.
2.00 pm	Prescription collection Our courier collects prescriptions from fertility clinics weekly, as not all clinics use e-scripts. These are processed promptly to avoid delays that could affect treatment timing.
3.30 pm	Patient support IVF supply often includes practical support: ensuring patients have what they need for transport and storage, and that any supporting materials and consumables are ready alongside the medicines.
6.00 pm	Engagement and training Some evenings may include a Fertility Nurses of Australia meeting, or delivering training sessions for fertility clinics for IVF clinicians and nurses.
8.00 pm	Urgent supply Occasionally I’ll get an out-of-hours call from an IVF clinician to arrange emergency medicines supply, requiring rapid coordination to keep treatment on track.

8.00 am	Set up and check in IVF work fluctuates – some days it’s minimal, other days it’s constant. I check what’s booked/expected, confirm any urgent needs, and make sure there’s space for IVF stock.
9.00 am	Ordering and supply planning Weekly ordering is done on Monday mornings and reviewed again on Wednesday because we can’t reliably order later in the week. This helps to protect continuity.
10:30 am	Dispensary coordination My dispensary manager leads ordering of IVF medicines, support materials and consumables. She also prepares syringe/needle packs for medicines that require separate consumable supply, so patients receive everything together.
12.00 pm	Clinic liaison Phone or email contact with IVF nurses occurs most days to clarify prescriptions, confirm timing and align supply with treatment cycles.
2.00 pm	Prescription collection Our courier collects prescriptions from fertility clinics weekly, as not all clinics use e-scripts. These are processed promptly to avoid delays that could affect treatment timing.
3.30 pm	Patient support IVF supply often includes practical support: ensuring patients have what they need for transport and storage, and that any supporting materials and consumables are ready alongside the medicines.
6.00 pm	Engagement and training Some evenings may include a Fertility Nurses of Australia meeting, or delivering training sessions for fertility clinics for IVF clinicians and nurses.
8.00 pm	Urgent supply Occasionally I’ll get an out-of-hours call from an IVF clinician to arrange emergency medicines supply, requiring rapid coordination to keep treatment on track.

1. Intranasal influenza vaccine introduced

2. The end of quadrivalent vaccines

3. Expanded registration of Fluad

4. Timing and urgency after a severe season

5. Vaccination rates remain dangerously low

More information for pharmacists

Pharmacist of the Year – Bente Hart MPS

Lifetime Achievement Award – Kate Gray MPS

Early Career Pharmacist of the Year – Mitchell Budden MPS

Intern of the Year – Karina Angelucci MPS

Knocking on doors

A workforce running on goodwill

The cost of saying no

Let pharmacists do what they are trained to do

Reform that matches need with value

How did you specialise in assisted reproductive therapy?

What does the role entail?

How do you help patients navigate their medicines regimen?

How do you manage medicines storage, cold-chain and supply?

How do you collaborate with fertility clinics, prescribers and nurses?

What advice do you have for ECPs keen on specialising in this area?

A Day in the life of Morag Horton, community pharmacy owner, Adelaide, South Australia

Compliance is key

Dispensing psychedelics safely

Managing patient enquiries

1. Intranasal influenza vaccine introduced

2. The end of quadrivalent vaccines

3. Expanded registration of Fluad

4. Timing and urgency after a severe season

5. Vaccination rates remain dangerously low

More information for pharmacists

Pharmacist of the Year – Bente Hart MPS

Lifetime Achievement Award – Kate Gray MPS

Early Career Pharmacist of the Year – Mitchell Budden MPS

Intern of the Year – Karina Angelucci MPS

Knocking on doors

A workforce running on goodwill

The cost of saying no

Let pharmacists do what they are trained to do

Reform that matches need with value

How did you specialise in assisted reproductive therapy?

What does the role entail?

How do you help patients navigate their medicines regimen?

How do you manage medicines storage, cold-chain and supply?

How do you collaborate with fertility clinics, prescribers and nurses?

What advice do you have for ECPs keen on specialising in this area?

A Day in the life of Morag Horton, community pharmacy owner, Adelaide, South Australia

Compliance is key

Dispensing psychedelics safely

Managing patient enquiries

1. Intranasal influenza vaccine introduced

2. The end of quadrivalent vaccines

3. Expanded registration of Fluad

4. Timing and urgency after a severe season

5. Vaccination rates remain dangerously low

More information for pharmacists

Pharmacist of the Year – Bente Hart MPS

Lifetime Achievement Award – Kate Gray MPS

Early Career Pharmacist of the Year – Mitchell Budden MPS

Intern of the Year – Karina Angelucci MPS

Knocking on doors

A workforce running on goodwill

The cost of saying no

Let pharmacists do what they are trained to do

Reform that matches need with value

How did you specialise in assisted reproductive therapy?

What does the role entail?

How do you help patients navigate their medicines regimen?

How do you manage medicines storage, cold-chain and supply?

How do you collaborate with fertility clinics, prescribers and nurses?

What advice do you have for ECPs keen on specialising in this area?

A Day in the life of Morag Horton, community pharmacy owner, Adelaide, South Australia

Compliance is key

Dispensing psychedelics safely

Managing patient enquiries

1. Intranasal influenza vaccine introduced

2. The end of quadrivalent vaccines

3. Expanded registration of Fluad

4. Timing and urgency after a severe season

5. Vaccination rates remain dangerously low